KMA and Co.
  • Why
  • Who
  • What
  • Where
  • Case Studies
  • Reports
  • Blog
Select Page
Digital Therapeutic Investment Soars — is there a bubble in our future?

Digital Therapeutic Investment Soars — is there a bubble in our future?

by Cassie Arnold | Jul 14, 2021 | Biotech Finance, Deal making, Digital Health, Digital Therapeutics, Investment, Venture capital

Digital therapeutic deal-making and venture investment continued up and to the right in the first half of 2021 – far up and to the right.  On the venture side, Rock Health reported that all digital health companies (including those that don’t have patient-facing...
Digital Therapeutic Deals Make Steady Progress in 2020

Digital Therapeutic Deals Make Steady Progress in 2020

by Cassie Arnold | Jan 28, 2021 | Biotech Finance, Deal making, Digital Health, Digital Therapeutics, Investment

After starting off 2020 with a 35 percent drop in the number of deals from the previous quarter, digital therapeutic deal-making steadily climbed over the course of 2020 to total 71 deals for the year. With 25 deals in the fourth quarter of 2020, the index was up 44...

Newsletter

Subscribe for notifications of new posts, and occasional other news from KMA & Company.




Recent Posts

  • Opportunity Costs
  • Let Me Repeat That
  • Numbers Tell Stories
  • Five Bits of Advice on MarCom Tactics
  • TL;DR*, Less is More, Short and Sweet

Categories

  • 21st Century Culture
  • Advertising
  • Biotech Finance
  • Branding
  • Communications
  • COVID
  • Deal making
  • Digital Health
  • Digital Therapeutic
  • Digital Therapeutics
  • Gender at Work
  • Investment
  • Modern Work
  • Persuasion
  • Sales
  • Venture capital
  • X
  • RSS
Copyright © 2025 KMA & Company